Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Sugar Land, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Tvardi Therapeutics, Inc. has filed 801 SEC EDGAR filings since 06 Dec 2005

SEC filing history

Showing 451-475 of 796 matching filings.

Per page
25
Current page
19
4

FORM 4 SUBMISSION

Filing date
05 Nov 2019
Reporting date
01 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Nov 2019
Reporting date
01 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
05 Nov 2019
Reporting date
05 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Oct 2019
Reporting date
25 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Oct 2019
Reporting date
18 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Oct 2019
Reporting date
11 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Oct 2019
Reporting date
04 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Oct 2019
Reporting date
01 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Oct 2019
Reporting date
01 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-233666

S-3ASR

Filing date
09 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Sep 2019
Reporting date
03 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Sep 2019
Reporting date
03 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Sep 2019
Reporting date
03 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
21 Aug 2019
Reporting date
20 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
07 Aug 2019
Reporting date
07 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Aug 2019
Reporting date
01 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Aug 2019
Reporting date
01 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Aug 2019
Reporting date
01 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
29 Jul 2019
Reporting date
24 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-230333

424B5

Filing date
25 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-230333

424B5

Filing date
24 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
24 Jul 2019
Reporting date
24 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jul 2019
Reporting date
17 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .